Additionally, it has been documented that LTF [40], TXLNA [41], LILRB2 [42], SLAMF6 [43], TP53 [38], IGFBP2 [39] are associated with the development of pancreatic cancer. This evidence concerns the gene TP53 and familial pancreatic carcinoma.